These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 6422900)

  • 1. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. III. Effect of antidepressants and lithium carbonate.
    Meltzer HY; Lowy M; Robertson A; Goodnick P; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):391-7. PubMed ID: 6422900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic function in the affective disorders: the effect of antidepressants and lithium on the 5-hydroxytryptophan-induced increase in serum cortisol.
    Meltzer HY
    Ann N Y Acad Sci; 1984; 430():115-37. PubMed ID: 6378031
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. II. Relation to suicide, psychosis, and depressive symptoms.
    Meltzer HY; Perline R; Tricou BJ; Lowy M; Robertson A
    Arch Gen Psychiatry; 1984 Apr; 41(4):379-87. PubMed ID: 6608336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania.
    Meltzer HY; Umberkoman-Wiita B; Robertson A; Tricou BJ; Lowy M; Perline R
    Arch Gen Psychiatry; 1984 Apr; 41(4):366-74. PubMed ID: 6608335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-hydroxytryptophan on H-reflex recovery curves in normal subjects and patients with affective disorders.
    Metz JT; Holcomb HH; Meltzer HY
    Biol Psychiatry; 1988 Mar; 23(6):602-11. PubMed ID: 3128339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine, but not tricyclic antidepressants, potentiates the 5-hydroxytryptophan-mediated increase in plasma cortisol and prolactin secretion in subjects with major depression or with obsessive compulsive disorder.
    Meltzer H; Bastani B; Jayathilake K; Maes M
    Neuropsychopharmacology; 1997 Jul; 17(1):1-11. PubMed ID: 9194044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychotropic drugs in internal medicine. I. Antidepressants].
    de la Fuente JR
    Rev Invest Clin; 1983; 35(3):247-56. PubMed ID: 6415779
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac effects of antidepressants.
    Donlon PT
    Geriatrics; 1982 Apr; 37(4):53-60. PubMed ID: 6800888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium in tricyclic-resistant depression. Correlation of increased brain 5-HT function with clinical outcome.
    Cowen PJ; McCance SL; Ware CJ; Cohen PR; Chalmers JS; Julier DL
    Br J Psychiatry; 1991 Sep; 159():341-6. PubMed ID: 1659918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lithium potentiation of tricyclic antidepressants following lack of T3 potentiation.
    Garbutt JC; Mayo JP; Gillette GM; Little KY; Mason GA
    Am J Psychiatry; 1986 Aug; 143(8):1038-9. PubMed ID: 3089033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortisol changes in long-term lithium therapy.
    Smigan L; Perris C
    Neuropsychobiology; 1984; 11(4):219-23. PubMed ID: 6436729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet intracellular calcium in patients with recurrent affective disorders.
    Bothwell RA; Eccleston D; Marshall E
    Psychopharmacology (Berl); 1994 Mar; 114(2):375-81. PubMed ID: 7838932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of antidepressants.
    Cassem N
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):22-9. PubMed ID: 6816788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The psychopharmacologic treatment of major depression.
    Stoudemire A
    J Med Assoc Ga; 1988 Nov; 77(11):821-4. PubMed ID: 3142958
    [No Abstract]   [Full Text] [Related]  

  • 16. Lithium as an adjunct in the treatment of major depression.
    Browne M; Lapierre YD; Hrdina PD; Horn E
    Int Clin Psychopharmacol; 1990 Apr; 5(2):103-10. PubMed ID: 2116474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affective disorders in the aged.
    Lehmann HE
    Psychiatr Clin North Am; 1982 Apr; 5(1):27-44. PubMed ID: 6124957
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.
    Haddjeri N; Szabo ST; de Montigny C; Blier P
    Neuropsychopharmacology; 2000 Apr; 22(4):346-56. PubMed ID: 10700654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats.
    Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T
    Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of antidepressants in use in the United States.
    Richelson E
    J Clin Psychiatry; 1982 Nov; 43(11 Pt 2):4-13. PubMed ID: 7174631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.